Aaron Schuchart | Chief Business Officer
Aeglea Biotherapeutics

Aaron Schuchart, Chief Business Officer, Aeglea Biotherapeutics

Mr. Schuchart leads the Business Development, Commercial Planning, and Intellectual Property functions at Aeglea. Prior to Aeglea, he served as Senior Vice President of Business Development and Strategic Alliances at Coherus Biosciences, where he helped grow the company from early platform stage to a fully integrated, late-stage clinical company. Prior to Coherus, Mr. Schuchart held numerous executive positions in business development, corporate planning, financial management, and operations at Novartis, Amgen, and Mendel Biotechnology. He has led or advised on numerous financing and strategic transactions, both inside companies and as an external advisor to privately funded biotech clients. Mr. Schuchart holds a B.S. in accounting from Texas Tech University, an M.B.A. from the UCLA Anderson School of Management, and is a Certified Licensing Professional (CLP).


World Orphan Drug Congress USA 2019 - Pre Conference Day @ 16:20

Uncovering New Medical Utility with Next Generation Enzyme Therapeutics

last published: 20/Mar/19 21:45 GMT

back to speakers